Business
Immuno-Oncology Drugs Market Opportunity Analysis and Forecast Report 2026-2035: Merck & Co. Remains a Dominant Force, Supported by the Commercial Success of Keytruda
The global immuno-oncology drugs market is expanding rapidly due to rising cancer prevalence and sustained clinical benefits. Opportunities include mRNA cancer vaccines and strategic collaborations to enhance innovation. However, high R&D costs remain a barrier, impacting pricing and access. North America leads the market. Immuno-Oncology Drugs Market Immuno-Oncology Drugs Market Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Drugs Market Size, Industry Dynamics, Opportunity Ana
About this update from Merck & Company, Inc.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"The global immuno-oncology drugs market is expanding rapidly due to rising cancer prevalence and sustained clinical benefits. Opportunities include mRNA cancer vaccines and strategic collaborations to enhance innovation. However, high R&D costs remain a barrier, impacting pricing and access. North America leads the market.","length":328,"tagName":"p"},{"type":"text","content":"Immuno-Oncology Drugs Market","length":28,"tagName":"p"},{"type":"image","alt":"Immuno-Oncology Drugs Market","displaySize":"","headline":null,"caption":"Immuno-Oncology Drugs Market","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/en/globenewswire.com/710ac75d51338f5307310953e3b6735f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/C4_X9KN8iCmUK2l9bIa_iw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MA--/https://media.zenfs.com/en/globenewswire.com/710ac75d51338f5307310953e3b6735f","width":600,"height":400}}},{"type":"text","content":"Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Drugs Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035" report has been added to ResearchAndMarkets.com's offering.The global immuno-oncology drugs market is undergoing rapid expansion as immune-based therapies become increasingly central to modern cancer treatment. In 2025, the market is valued at US$ 35.78 billion and is projected to reach US$ 185.69 billion by 2035. This growth corresponds to a CAGR of 17.9% from 2026 to 2035, highlighting the accelerating pace of adoption and development across oncology care. ","length":626,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/...